European Urology Oncology

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Volume 72, Issue 3, Pages (September 2017)
Volume 53, Issue 3, Pages (March 2008)
Alternative Treatments for Localized Prostate Cancer
Rectourethral Fistula After High-intensity Focused Ultrasound Therapy for Prostate Cancer and Its Surgical Management  Christopher Netsch, Thorsten Bach,
Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction? 
Volume 62, Issue 3, Pages (September 2012)
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for.
Volume 58, Issue 4, Pages (October 2010)
Volume 4, Issue 5, Pages (September 2017)
Testosterone Therapy in Men With Prostate Cancer
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Prostate Cancer: Highlights from 2006
Volume 53, Issue 5, Pages (May 2008)
Volume 69, Issue 1, Pages (January 2016)
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 
Volume 73, Issue 3, Pages (March 2018)
Volume 65, Issue 5, Pages (May 2014)
Hormone Therapy for Prostate Cancer: Exploring Current Controversies
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Prostate Cancer Epidemic in Sight?
European Urology Oncology
Volume 61, Issue 1, Pages (January 2012)
Volume 68, Issue 5, Pages (November 2015)
Volume 67, Issue 2, Pages (February 2015)
What is New in Hormone Therapy for Prostate Cancer in 2007?
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Volume 62, Issue 1, Pages (July 2012)
Volume 56, Issue 2, Pages (August 2009)
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
Prostate Cancer Epidemic in Sight?
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Volume 70, Issue 6, Pages (December 2016)
Volume 71, Issue 1, Pages (January 2017)
Volume 53, Issue 6, Pages (June 2008)
Volume 56, Issue 1, Pages (July 2009)
Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria.
Volume 68, Issue 6, Pages e134-e135 (December 2015)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
European Urology Oncology
Optimising Hormone Therapy in Advanced Disease
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study  Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
European Urology Oncology
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Long-Term Hormonal Therapy: Who Would Benefit?
European Urology Oncology
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
European Urology Oncology
European Urology is “Your” Journal
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Volume 50, Issue 5, Pages (November 2006)
Axel Heidenreich  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection.
European Urology Oncology
Axel Heidenreich  European Urology Supplements 
Volume 51, Issue 5, Pages (May 2007)
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
European Urology Oncology
European Urology Oncology
Presentation transcript:

European Urology Oncology Consulting “Dr. Google” for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis  Giovanni E. Cacciamani, Silvia Bassi, Marco Sebben, Anna Marcer, Giorgio I. Russo, Andrea Cocci, Paolo Dell’Oglio, Luis G. Medina, Nima Nassiri, Alessandro Tafuri, Andre Abreu, Antonio B. Porcaro, Alberto Briganti, Francesco Montorsi, Inderbir S. Gill, Walter Artibani  European Urology Oncology  DOI: 10.1016/j.euo.2019.07.002 Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 1 Google Trends relative search volume for PCa treatment options compared with radical prostatectomy by month, January 2004 to August 2018: (A) active surveillance, (B) radiation therapy, (C) hormonal therapy, and (D) focal therapy. PCa treatment searches were reported graphically with “radical prostatectomy” search since radical prostatectomy represents the gold standard treatment for PCa. AAPC = average annual percentage change; PCa = prostate cancer. European Urology Oncology DOI: (10.1016/j.euo.2019.07.002) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 2 Google Trends relative search volume for PCa treatment options compared with radical prostatectomy by month, January 2004 to August 2018: (A) HIFU, (B) cryoablation, (C) ablation therapy, (D) brachytherapy, and (E) photodynamic therapy. PCa treatment searches were reported graphically with “radical prostatectomy” search since radical prostatectomy represents the gold standard treatment for PCa. AAPC = average annual percentage change; HIFU = high-intensity focused ultrasound; PCa = prostate cancer. European Urology Oncology DOI: (10.1016/j.euo.2019.07.002) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 3 Mean ARSV PCa treatment comparison before and after NCCN guidelines and USPSTF screening recommendation. AS = active surveillance; ATh = ablation therapy; BTh = brachytherapy; CTh = cryotherapy; FTh = focal therapy; HIFU = high-intensity focused ultrasound; HTh = hormonal therapy; NCCN = National Comprehensive Cancer Network; PCa = prostate cancer; PDTh = photodynamic therapy; RP = radical prostatectomy; RTh = radiation therapy; USPSTF = US Preventive Service Task Force. European Urology Oncology DOI: (10.1016/j.euo.2019.07.002) Copyright © 2019 European Association of Urology Terms and Conditions